Targeting Mutant V600EB‐Raf in Melanoma Interrupts Immunoediting of Leukocyte Functions and Melanoma Extravasation

Polymorphonuclear neutrophils (PMN) facilitate melanoma cell extravasation under dynamic flow conditions by the binding of intercellular adhesion molecule-1 (ICAM-1) on melanoma cells to beta2 integrins on PMNs, which is mediated by endogenously produced chemokine interleukin 8 (IL-8) from the tumor microenvironment. However, little is known about the role of B-Raf, the most mutated gene in malignant melanomas, in this process. In this study, we investigated the functional importance of B-Raf in melanoma extravasation by using short interfering RNA to reduce expression/activity of mutant (V600E)B-Raf in melanoma. Results indicated that knockdown of mutant (V600E)B-Raf inhibited melanoma cell extravasation in vitro and subsequent lung metastasis development in vivo. Mechanistic studies showed that inhibition of (V600E)B-Raf significantly reduced the constitutive secretion of IL-8 from melanoma cells as well as the capacity of endogenous IL-8 production from the melanoma-PMN microenvironment. Furthermore, a reduction in ICAM-1 expression on melanoma cells was detected following mutant (V600E)B-Raf knockdown. Together, these results suggest that targeting mutant (V600E)B-Raf reduces melanoma cell extravasation by decreasing IL-8 production and interrupting ICAM-1-beta2 integrin binding of melanoma cells to the endothelium mediated by PMNs in the microcirculation, which provides a rationale and mechanistic basis for targeting mutant (V600E)B-Raf to inhibit melanoma extravasation and subsequent metastasis development.

[1]  Douglas B. Evans,et al.  The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells , 1999 .

[2]  P. Dhawan,et al.  A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. , 2002, The Journal of biological chemistry.

[3]  T. Kawabe,et al.  Different Effects of Point Mutations within the B-Raf Glycine-Rich Loop in Colorectal Tumors on Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase and Nuclear Factor κB Pathway and Cellular Transformation , 2004, Cancer Research.

[4]  Cheng Dong,et al.  Distinct role of hydrodynamic shear in leukocyte-facilitated tumor cell extravasation. , 2005, American journal of physiology. Cell physiology.

[5]  J. McCubrey,et al.  Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). , 2003, International journal of oncology.

[6]  J. Hoyland,et al.  Degeneration of intervertebral discs: current understanding of cellular and molecular events, and implications for novel therapies , 2001, Expert Reviews in Molecular Medicine.

[7]  L. Liotta,et al.  Responses of tumor cell pseudopod protrusion to changes in medium osmolality , 1996, Journal of cellular physiology.

[8]  Cheng Dong,et al.  Shear stress and shear rate differentially affect the multi-step process of leukocyte-facilitated melanoma adhesion. , 2005, Experimental cell research.

[9]  D. Tuveson,et al.  Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. , 2005, Cancer research.

[10]  P. Meltzer,et al.  High frequency of BRAF mutations in nevi , 2003, Nature Genetics.

[11]  Ann Richmond,et al.  NF-κB, chemokine gene transcription and tumour growth , 2002, Nature Reviews Immunology.

[12]  M. Slattery,et al.  Melanoma cell extravasation under flow conditions is modulated by leukocytes and endogenously produced interleukin 8. , 2005, Molecular & cellular biomechanics : MCB.

[13]  D. Polsky,et al.  Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. , 2003, Cancer research.

[14]  Timothy A. Springer,et al.  The dynamic regulation of integrin adhesiveness , 1994, Current Biology.

[15]  C. Pritchard,et al.  Raf proteins and cancer: B-Raf is identified as a mutational target. , 2003, Biochimica et biophysica acta.

[16]  M. Flaig,et al.  Mutations of the BRAF gene in benign and malignant melanocytic lesions. , 2003, The Journal of investigative dermatology.

[17]  Cheng Dong,et al.  In Vitro Characterization and Micromechanics of Tumor Cell Chemotactic Protrusion, Locomotion, and Extravasation , 2002, Annals of Biomedical Engineering.

[18]  J. Johnson,et al.  12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. , 1994, The Journal of biological chemistry.

[19]  S I Simon,et al.  Neutrophil CD18-dependent arrest on intercellular adhesion molecule 1 (ICAM-1) in shear flow can be activated through L-selectin. , 1997, Journal of immunology.

[20]  D. Welch,et al.  Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides. , 1994, Experimental cell research.

[21]  Cheng Dong,et al.  Regulation of interleukin-8 expression in melanoma-stimulated neutrophil inflammatory response. , 2007, Experimental cell research.

[22]  M. Baggiolini,et al.  Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. , 1991, Journal of immunology.

[23]  T. Wirth,et al.  Raf induces NF-kappaB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Robertson,et al.  Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases. , 2006, Cancer research.

[25]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[26]  Two phases of pseudopod protrusion in tumor cells revealed by a micropipette. , 1994, Microvascular research.

[27]  G. Clayman,et al.  Chemokines in cancer , 2001, Expert Reviews in Molecular Medicine.

[28]  Richard Wooster,et al.  BRAF and RAS mutations in human lung cancer and melanoma. , 2002, Cancer research.

[29]  Christopher J. Miller,et al.  Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasms. , 2004, The Journal of investigative dermatology.

[30]  Cheng Dong,et al.  Neutrophils influence melanoma adhesion and migration under flow conditions , 2003, International journal of cancer.

[31]  L. Hodgson,et al.  Melanoma cell migration to type IV collagen requires activation of NF-kappaB. , 2003, Oncogene.

[32]  M. Baggiolini,et al.  Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils , 1990, The Journal of experimental medicine.

[33]  A. Hartmann,et al.  Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. , 1999, The American journal of pathology.

[34]  D. Welch,et al.  Metastasis suppressor pathways--an evolving paradigm. , 2003, Cancer letters.

[35]  J. Wang,et al.  Human neutrophils facilitate tumor cell transendothelial migration. , 2001, American journal of physiology. Cell physiology.

[36]  L. Desjardins,et al.  BRAF as a melanoma susceptibility candidate gene? , 2003, Cancer research.

[37]  T. Kawabe,et al.  Functional analysis of mutations within the kinase activation segment of B-Raf in human colorectal tumors. , 2003, Cancer research.

[38]  J. Cheng,et al.  Deregulated Akt3 Activity Promotes Development of Malignant Melanoma , 2004, Cancer Research.